Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07178626 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Association of Biomarkers and Gastric Antral Motility Index With Feeding Intolerance in Critically Ill Patients

StatusRecruiting
PhaseNot specified
Started2025-10-20
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jul 31, 2026 → Dec 31, 2026
See other at-risk trials from The First Hospital of Jilin University

Amendment history

2026-09-02
Study Status, Contacts/Locations v2
Trial status changed: Enrolling by Invitation → Recruiting
Primary completion pushed: 2026-07-31 → 2026-12-31
Study sitesdetails revised at 1 of 1 site
2025-12-29
Not Yet Recruiting→Enrolling by Invitation Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Enrolling by Invitation
Study sites0→1
2025-09-10
Original filing
When the subjects are admitted to the department, the researchers will monitor potential biomarkers of gastrointestinal injury before administering enteral nutrition (a small amount of blood is drawn, serum is separated by centrifugation, and the serum sample is frozen for final centralized biomarker detection), and measure the antral movement index under ultrasound (300ml of warm water is injected into the stomach before measurement, and then the antral movement is observed for 6 minutes) Then, monitor whether the patient has developed feeding intolerance within 7 days of the ICU
Trial Details
NCT Number NCT07178626
Lead Sponsor The First Hospital of Jilin University
Conditions Critically Ill Patients Who Are Not Allowed to Eat Orally But Can Initiate Enteral Nutrition Within 48 Hours of ICU
Enrollment 160 participants
Start Date 2025-10-20
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-03